Subjective Cognitive Complaints in Parkinson's Disease: A Systematic Review and Meta‐Analysis
M Siciliano, A Tessitore, F Morgante… - Movement …, 2024 - Wiley Online Library
Abstract Background Subjective cognitive complaints (SCCs) in Parkinson's disease (PD)
are reported frequently, but their prevalence and association with changes on objective …
are reported frequently, but their prevalence and association with changes on objective …
Subjective cognitive complaint in Parkinson's disease patients with normal cognition: canary in the coal mine?
Objective The objective of this study was to determine the frequency and impact of
subjective cognitive complaint (SCC) in Parkinson's disease (PD) patients with normal …
subjective cognitive complaint (SCC) in Parkinson's disease (PD) patients with normal …
[HTML][HTML] Subjective cognitive complaints in cognitively normal patients with Parkinson's disease: a systematic review
JY Hong, PH Lee - Journal of Movement Disorders, 2023 - ncbi.nlm.nih.gov
Subjective cognitive complaints (SCCs) refer to self-perceived cognitive decline and are
related to objective cognitive decline. SCCs in cognitively normal individuals are considered …
related to objective cognitive decline. SCCs in cognitively normal individuals are considered …
Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease
D Weintraub, C Marras, A Amara… - Movement …, 2024 - Wiley Online Library
Background Early identification of subjective cognitive complaints (SCC) in Parkinson's
disease (PD) may improve patient care if it predicts cognition‐related functional impairment …
disease (PD) may improve patient care if it predicts cognition‐related functional impairment …
The Montreal Cognitive Assessment: is it suitable for identifying mild cognitive impairment in Parkinson's Disease?
S Rosenblum, S Meyer, N Gemerman… - Movement Disorders …, 2020 - Wiley Online Library
Background Administering an abbreviated global cognitive test, such as the Montreal
Cognitive Assessment (MoCA), is necessary for the recommended first‐level diagnostic …
Cognitive Assessment (MoCA), is necessary for the recommended first‐level diagnostic …
Subjective cognitive complaints in patients with Parkinson's disease
PL Kjeldsen, MF Damholdt - Acta Neurologica Scandinavica, 2019 - Wiley Online Library
Mild cognitive impairment (MCI) is common in Parkinson's disease (PD), affecting almost all
patients with PD at some time. It has been shown that patients with PD, who express …
patients with PD at some time. It has been shown that patients with PD, who express …
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
D Weintraub, T Simuni, C Caspell‐Garcia… - Movement …, 2015 - Wiley Online Library
This study was undertaken to determine the prevalence and correlates of cognitive
impairment (CI) and neuropsychiatric symptoms (NPS) in early, untreated patients with …
impairment (CI) and neuropsychiatric symptoms (NPS) in early, untreated patients with …
Modifiable risk factors for cognitive impairment in Parkinson's disease: a systematic review and meta‐analysis of prospective cohort studies
Y Guo, W Xu, FT Liu, JQ Li, XP Cao, L Tan… - Movement …, 2019 - Wiley Online Library
Background Cognitive impairment is a common and devastating manifestation in
Parkinson's disease (PD). We aimed to identify modifiable risk factors for PD with cognitive …
Parkinson's disease (PD). We aimed to identify modifiable risk factors for PD with cognitive …
Neuropsychiatric symptoms are associated with dementia in Parkinson's disease but not predictive of it
ABSTRACT Background Neuropsychiatric symptoms in Parkinson's disease (PD) may
increase dementia (PDD) risk. The predictive value of these symptoms, however, has not …
increase dementia (PDD) risk. The predictive value of these symptoms, however, has not …
Modifiable comorbidities associated with cognitive decline in Parkinson's disease
Background Cognitive impairment (CI) is one of the most feared and debilitating
complications of PD. No therapy has been shown to slow or prevent CI in PD. Objective To …
complications of PD. No therapy has been shown to slow or prevent CI in PD. Objective To …
相关搜索
- meta analysis parkinson's disease
- meta analysis cognitive impairment
- neuropsychiatric symptoms parkinson's disease
- cognitive impairment parkinson's disease
- meta analysis risk factors
- risk factors parkinson's disease
- modifiable comorbidities parkinson's disease
- cognitive performance neuropsychiatric symptoms
- cognitive impairment risk factors
- modifiable comorbidities cognitive decline
- cognitive decline parkinson's disease
- cognitive performance parkinson's disease